Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
avoid, confidence, dedicated, deliberating, description, diligently, diminish, dissolve, impede, investor, IRS, merger, midpoint, numerator, PCAOB, pose, remediate, shareholder, simplified, threshold, unintended
Removed:
abroad, absent, absorb, academic, acceptable, acceptance, accidental, account, acid, adequately, administer, administering, alternative, amino, apparent, area, arising, begin, billion, BLA, block, breaching, budget, called, carry, carryback, chosen, clinically, COBRA, collected, commencement, commercializing, commercially, competing, complaint, confer, confidentiality, confirming, consecutive, constitute, continuity, convert, deconsolidate, deconsolidation, defending, deficient, define, delaying, demand, demonstrate, demonstrated, dental, denying, designing, desirable, desired, differentiated, differentiation, dilute, disaster, discharge, discontinue, discovered, dismissed, displace, distract, District, DOD, earthquake, easier, easily, eligibility, eliminate, encountered, enforceable, enforced, enforcing, enrolling, entering, entity, entry, equitable, erode, erosion, establishment, estimation, Europe, exchanged, executing, exerted, exit, expanded, expend, expended, extinguished, extremely, faced, failed, FASB, fault, favor, feasible, flow, Food, formal, forward, found, frequency, fuel, generated, generation, GMP, goodwill, group, guaranteed, half, hard, headcount, hedge, hedged, hedging, higher, holding, Honorable, hypothetical, immunogenic, impairment, imposed, improve, inability, inconclusive, IND, infringe, initiation, injunctive, insignificant, insufficient, intangible, integrate, integrating, intense, interrupt, interruption, invalidate, investee, investigational, justify, knowledgeable, laboratory, laddering, lawsuit, leading, learn, legislation, light, localized, logistical, logistically, lost, lump, manufactured, manufacturer, marketplace, MC, meaningful, meaningfully, missed, misuse, modifying, morale, narrowed, necessitate, negligible, NIH, noncompetitive, nucleic, obsolete, opportunity, optimization, orderly, packaging, passed, perception, periodic, power, practicing, precluding, prematurely, prepaid, productive, profitable, prohibitive, promising, proposed, proprietor, prospective, protecting, protocol, purpose, qualitative, quality, quantitative, ranged, rapid, rapidly, reach, reached, recovery, redirection, refund, regular, reimbursement, relied, relief, renewed, repeat, resolved, resource, restriction, resultant, retention, reversed, reviewing, revised, revocation, Royal, SAS, satisfactorily, satisfied, scale, Scheindlin, secondary, secret, Shell, Shira, shut, Similarly, single, size, Southern, speculative, strictly, strong, subsequently, succeed, sufficiently, suitability, sum, supply, susceptible, sustained, target, targeted, targeting, team, technically, technological, technologically, terminating, timetable, transfer, translation, transparency, transportation, undergo, undesirable, unforeseen, unwilling, valid, variant, varying, version, VII, vision, warrant, workforce, worldwide, worthwhile, write, York
Filing tables
Filing exhibits
Related press release
MAXY similar filings
Filing view
External links
Exhibit 32.1
Certification of Chief Executive Officer and Chief Financial Officer
Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
I, James R. Sulat, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge the Annual Report of Maxygen, Inc. on Form 10-K for the annual period ended December 31, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of Maxygen, Inc.
By: | /s/ James R. Sulat | |
Name: | James R. Sulat | |
Title: | Chief Executive Officer & Chief Financial Officer | |
Date: | March 12, 2013 |